Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.
about
Mepolizumab versus placebo for asthmaOmalizumab for asthma in adults and childrenChallenges and Current Efforts in the Development of Biomarkers for Chronic Inflammatory and Remodeling Conditions of the LungsEosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary diseaseBiomarkers and severe asthma: a critical appraisalMurine models of inflammatory bowel disease (IBD): challenges of modeling human diseaseDefining severe asthma - an approach to find new therapiesTailored therapy for severe asthmaUsing Periostin as a Biomarker in the Treatment of AsthmaSevere asthma: anti-IgE or anti-IL-5?Biomarkers for the Phenotyping and Monitoring of Asthma in ChildrenPersonalized Medicine in AllergyDevelopment of New Therapies for Severe AsthmaMepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potentialBiomarkers in the Management of Difficult AsthmaPersonalized health care beyond oncology: new indications for immunoassay-based companion diagnosticsBiologics in asthma--the next step toward personalized treatmentPhenotypes in obstructive sleep apnea: A definition, examples and evolution of approaches.Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma.Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.Genetic and epigenetic underpinnings of eosinophilic esophagitisRelationship of Allergy with Asthma: There Are More Than the Allergy "Eggs" in the Asthma "Basket".Update in asthma 2013Emerging Endotypes of Chronic Rhinosinusitis and Its Application to Precision Medicine.Evolving Concepts of Asthma.Small airways dysfunction in asthma: evaluation and management to improve asthma control.Against all odds: anti-IgE for intrinsic asthma?Novel targeted therapies for eosinophil-associated diseases and allergyPediatric asthma: guidelines-based care, omalizumab, and other potential biologic agents.Asthma control and cognitive function in a cohort of elderly adultsAsthma-COPD overlap. Clinical relevance of genomic signatures of type 2 inflammation in chronic obstructive pulmonary disease.Seasonal risk factors for asthma exacerbations among inner-city childrenPeriostin levels and eosinophilic inflammation in poorly-controlled asthmaPreseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.New and emerging therapies for asthma.Effectiveness of omalizumab in an asthmatic patient with severe airway and blood eosinophilia.A randomized trial of the efficacy and safety of quilizumab in adults with inadequately controlled allergic asthma.Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.Serum periostin in obstructive airways diseaseRoles of Periostin in Respiratory Disorders.
P2860
Q24186306-CD0E8915-A3CE-44B6-9135-28E4B2F812E5Q24201145-0BA246DF-B91D-48A4-A2C5-D06999DC9043Q26766294-F026B9A4-7C21-4D63-AB8D-030979AABBDEQ26771819-7E220A3A-D2A6-4B60-9CA1-09EB6AD531C4Q26782718-453C0D33-D189-47AD-99F9-B7543382FE91Q26863622-5875F080-C777-428C-96C9-B28DD90C1429Q27001054-3C200177-6B8C-4067-8667-93747823D91EQ27016035-FF30B2CB-2182-4167-9898-01D0FAA7E31CQ28067637-C2914372-5E44-492D-B193-207210BA6666Q28071832-C56DBD67-7468-40D1-83EE-2ABFE9C70A21Q28072326-EC8C61E3-4CA2-44C2-A974-C38382057D46Q28073074-B87A4662-8766-4E07-97B8-6155ECA5EE0CQ28077546-DEF413C8-3C50-4C23-9F6E-E4B7992D9104Q28080207-B27108DE-0783-4608-A4FA-8A50386C0B9EQ28081109-6756F961-91B9-47C8-A04F-173A80F01B8BQ28084590-43FB8F47-8322-4AA4-A95D-5D6619B2AC8FQ28085614-C80F1C10-D924-4E28-94F8-79667FEB2E5AQ30241786-4C2C7265-8F92-466D-B40D-A24187706D21Q30275238-6D5BBB5D-1441-4590-AE09-348CAD0652C3Q30276073-6E17DFC4-194E-4769-AA0D-2CF1D33D97BEQ33606257-D9E18307-0602-4BD8-931A-322B262E5030Q33611380-BD370440-C41C-4E74-B6D6-DE46E66665B6Q33732168-572ED5CD-D0AD-4EDE-B1D5-EBD3E34D4AEBQ33734329-4C198B18-8992-4864-97B3-A68DE26389E1Q33735605-955BA932-47A9-4254-8A26-6C4F0D7859FDQ34167882-C2F62D2D-2396-43FF-8FC8-DDE284F650F1Q34346950-1FBC382E-CE1A-408B-A6BE-CF271124F248Q34444620-29189F0E-C2E9-4DF3-9E51-03A2D01A08D1Q34625206-324AD897-113B-4878-AD5E-8CD4D9297B01Q35528157-468D9941-29A3-4478-B13C-A342EC3E26BFQ35530899-A8D20449-5930-471A-A5FB-6B260578F684Q35706430-27A841CE-40CA-4F0F-A3BC-D542C19BF52FQ36003967-93257C35-40FD-45F2-8CB0-3A5360DFB1D7Q36373455-C8B1923E-419F-4BA9-87A7-0DA380A692AAQ36409355-1360FA69-8189-4D8D-B747-A6DDFE03A880Q36418905-61912015-C1EC-4717-B735-B982241308C7Q36700648-B43F5359-954D-41E1-BE56-9104BE0B24A6Q36828893-AD641110-8922-42B1-B598-6A8ADFE114D4Q36854205-01572EA8-8428-4ABD-B97F-EF3E1993CBF5Q36916018-336824AB-4CC7-49DC-B676-9FE7DB8EEB18
P2860
Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Exploring the effects of omali ...... biomarkers in the EXTRA study.
@en
Exploring the effects of omali ...... biomarkers in the EXTRA study.
@nl
type
label
Exploring the effects of omali ...... biomarkers in the EXTRA study.
@en
Exploring the effects of omali ...... biomarkers in the EXTRA study.
@nl
prefLabel
Exploring the effects of omali ...... biomarkers in the EXTRA study.
@en
Exploring the effects of omali ...... biomarkers in the EXTRA study.
@nl
P2093
P2860
P50
P1476
Exploring the effects of omali ...... biomarkers in the EXTRA study.
@en
P2093
Hsin-Ju Hsieh
Jeffrey M Harris
Joseph R Arron
Karin Rosén
Preeti Lal
Sally Wenzel
Sofia Mosesova
P2860
P304
P356
10.1164/RCCM.201208-1414OC
P407
P577
2013-04-01T00:00:00Z